Literature DB >> 9313869

Synthesis, structure and quantitative structure-activity relationships of sigma receptor ligands, 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl) piperazines.

K Fujimura1, J Matsumoto, M Niwa, T Kobayashi, Y Kawashima, Y In, T Ishida.   

Abstract

A set of the title compounds having different substituents (R1, R2) on their phenyl groups was synthesized to find sigma receptor binding affinity. Among the compounds, 2b (R1 = R2 = Cl) has the most potent sigma 1-binding activity, while 2a (R1 = R2 = H, SA4503) was most selective to sigma 1 over sigma 2 receptor. The crystal structures of 2a and 2b were shown, by X-ray crystallography, to be similar except for the one torsional angle of their propylene parts. Quantitative structure-activity relationship study suggested the affinity of the compounds to the sigma 1 receptor was dependent on the electronic feature, Swain-Lupton's R or Sz that was derived by molecular orbital method, of R1 and R2.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9313869     DOI: 10.1016/s0968-0896(97)00093-x

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  10 in total

1.  The sigma receptor agonist SA4503 both attenuates and enhances the effects of methamphetamine.

Authors:  Kelli R Rodvelt; Clark E Oelrichs; Lucas R Blount; Kuo-Hsien Fan; Susan Z Lever; John R Lever; Dennis K Miller
Journal:  Drug Alcohol Depend       Date:  2011-02-01       Impact factor: 4.492

2.  Wildtype sigma-1 receptor and the receptor agonist improve ALS-associated mutation-induced insolubility and toxicity.

Authors:  Yasuharu Shinoda; Yudai Haga; Koichiro Akagawa; Kohji Fukunaga
Journal:  J Biol Chem       Date:  2020-10-14       Impact factor: 5.157

3.  N-phenylpropyl-N'-substituted piperazines occupy sigma receptors and alter methamphetamine-induced hyperactivity in mice.

Authors:  Dennis K Miller; Eric S Park; Susan Z Lever; John R Lever
Journal:  Pharmacol Biochem Behav       Date:  2016-11-13       Impact factor: 3.533

4.  Ether modifications to 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine (SA4503): effects on binding affinity and selectivity for sigma receptors and monoamine transporters.

Authors:  Rong Xu; Sarah A Lord; Ryan M Peterson; Emily A Fergason-Cantrell; John R Lever; Susan Z Lever
Journal:  Bioorg Med Chem       Date:  2014-11-11       Impact factor: 3.641

5.  Catalytic, asymmetric difluorination of alkenes to generate difluoromethylated stereocenters.

Authors:  Steven M Banik; Jonathan William Medley; Eric N Jacobsen
Journal:  Science       Date:  2016-07-01       Impact factor: 47.728

6.  The sigma receptor ligand N-phenylpropyl-N'-(4-methoxyphenethyl)3piperazine (YZ-067) enhances the cocaine conditioned-rewarding properties while inhibiting the development of sensitization of cocaine in mice.

Authors:  Melissa A Tapia; Andrew S Sage; Emma I Fullerton; Jessica M Judd; Paige C Hildebrant; Matthew J Will; Susan Z Lever; John R Lever; Dennis K Miller
Journal:  Psychopharmacology (Berl)       Date:  2019-12-10       Impact factor: 4.530

7.  Wildtype σ1 receptor and the receptor agonist improve ALS-associated mutation-induced insolubility and toxicity.

Authors:  Yasuharu Shinoda; Yudai Haga; Koichiro Akagawa; Kohji Fukunaga
Journal:  J Biol Chem       Date:  2020-12-18       Impact factor: 5.157

8.  Corticosteroids Mediate Heart Failure-Induced Depression through Reduced σ1-Receptor Expression.

Authors:  Yasuharu Shinoda; Hideaki Tagashira; Md Shenuarin Bhuiyan; Hideyuki Hasegawa; Hiroshi Kanai; Chen Zhang; Feng Han; Kohji Fukunaga
Journal:  PLoS One       Date:  2016-10-14       Impact factor: 3.240

9.  SA4503, A Potent Sigma-1 Receptor Ligand, Ameliorates Synaptic Abnormalities and Cognitive Dysfunction in a Mouse Model of ATR-X Syndrome.

Authors:  Kouya Yamaguchi; Norifumi Shioda; Yasushi Yabuki; Chen Zhang; Feng Han; Kohji Fukunaga
Journal:  Int J Mol Sci       Date:  2018-09-18       Impact factor: 5.923

10.  Simple ammonium salts acting on sigma-1 receptors yield potential treatments for cancer and depression.

Authors:  James M Brimson; Kiran K Akula; Haider Abbas; David R Ferry; Shrinivas K Kulkarni; Steven T Russell; Michael J Tisdale; Tewin Tencomnao; Stephen T Safrany
Journal:  Sci Rep       Date:  2020-06-08       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.